| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს ნიუ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾21.9m₾18.3m |
| Revenue growth | -100.0% | 19.6% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾3.5m₾5.3m |
| EBITDA margin | -29687.2%-11.6% | 15.8%29.2% |
| Net profit | -₾258k-₾726k | ₾2.1m₾4.6m |
| Net margin | -29249.2%-17.7% | 9.7%24.9% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾10.9m₾13.2m |
| Total equity | -₾780k-₾522k | ₾5.9m₾5.5m |
| ROE | — | 36.1%82.8% |